The majority of pancreatic carcinomas contain a mutation at codon 12 of the
K-ras oncogene. We have analysed 87 samples from 76 patients who underwent
surgery because of different pancreatic diseases to evaluate whether the d
etection of K-ras mutations may be helpful to discriminate between chronic
inflammation and neoplastic growth. Mutation analysis was performed using a
semi-nested PCR followed by a selective restriction enzyme digestion. The
correlation of clinical follow ups with the results of the molecular analys
is was performed from 47 patients. K-ras mutations were detected in 50% of
adenocarcinomas and no point mutation was found in normal pancreatic tissue
and in tumor tissue from entities other than pancreas. Otherwise, K-ras mu
tations were detected in tissue samples from two patients with chronic panc
reatitis, and one patient was found to have an adenocarcinoma after additio
nal clinical investigation. Further studies especially follow ups will be h
elpful to get a better insight into the pathogenesis of pancreatic tumors a
nd may be useful as an early diagnostic test.